A detailed history of Bml Capital Management, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 2,000,000 shares of AADI stock, worth $3.92 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares
2,000,000
Holding current value
$3.92 Million
% of portfolio
2.42%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$1.32 - $2.06 $2.64 Million - $4.12 Million
2,000,000 New
2,000,000 $4.12 Billion

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $41.2M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.